NO930825L - Spesifikke bindingsreagenser - Google Patents
Spesifikke bindingsreagenserInfo
- Publication number
- NO930825L NO930825L NO93930825A NO930825A NO930825L NO 930825 L NO930825 L NO 930825L NO 93930825 A NO93930825 A NO 93930825A NO 930825 A NO930825 A NO 930825A NO 930825 L NO930825 L NO 930825L
- Authority
- NO
- Norway
- Prior art keywords
- human antibody
- reshaped
- specific binding
- binding reagents
- hmfg1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Nonmetallic Welding Materials (AREA)
- Pretreatment Of Seeds And Plants (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909019553A GB9019553D0 (en) | 1990-09-07 | 1990-09-07 | Specific binding agents |
PCT/GB1991/001511 WO1992004380A1 (en) | 1990-09-07 | 1991-09-05 | Specific binding agents |
Publications (3)
Publication Number | Publication Date |
---|---|
NO930825D0 NO930825D0 (no) | 1993-03-05 |
NO930825L true NO930825L (no) | 1993-05-05 |
NO314595B1 NO314595B1 (no) | 2003-04-14 |
Family
ID=10681827
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19930825A NO314595B1 (no) | 1990-09-07 | 1993-03-05 | Fremgangsmåte for fremstilling av et kim¶rt terapeutisk aktivt humanisert antistoff eller et terapeutisk aktivt fragment derav, DNA-sekvenssom koder for antistoffet, samt plasmid og stabil vertscellelinje som omfatterDNA-sekvensen |
NO20014822A NO315239B1 (no) | 1990-09-07 | 2001-10-04 | Kim¶rt humanisert antistoff eller fragment derav, samt anvendelse av samme |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20014822A NO315239B1 (no) | 1990-09-07 | 2001-10-04 | Kim¶rt humanisert antistoff eller fragment derav, samt anvendelse av samme |
Country Status (18)
Country | Link |
---|---|
US (2) | US6204366B1 (no) |
EP (1) | EP0483961B1 (no) |
JP (2) | JP3514456B2 (no) |
KR (1) | KR930702526A (no) |
AT (1) | ATE233279T1 (no) |
AU (1) | AU653167B2 (no) |
BG (1) | BG60716B1 (no) |
CA (1) | CA2090961C (no) |
DE (1) | DE69133200T2 (no) |
DK (1) | DK0483961T3 (no) |
ES (1) | ES2193129T3 (no) |
FI (2) | FI113873B (no) |
GB (1) | GB9019553D0 (no) |
HU (2) | HUT67796A (no) |
NO (2) | NO314595B1 (no) |
RO (1) | RO113432B1 (no) |
UA (1) | UA46691C2 (no) |
WO (1) | WO1992004380A1 (no) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994004679A1 (en) * | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
US6407213B1 (en) | 1991-06-14 | 2002-06-18 | Genentech, Inc. | Method for making humanized antibodies |
US6800738B1 (en) | 1991-06-14 | 2004-10-05 | Genentech, Inc. | Method for making humanized antibodies |
US5869619A (en) * | 1991-12-13 | 1999-02-09 | Xoma Corporation | Modified antibody variable domains |
CA2507749C (en) * | 1991-12-13 | 2010-08-24 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
WO1994011508A2 (en) * | 1992-11-13 | 1994-05-26 | Cancer Research Fund Of Contra Costa | Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods |
JPH09503901A (ja) * | 1992-11-16 | 1997-04-22 | キャンサー リサーチ ファンド オブ コントラ コスタ | 広範な新生物特異性を有するペプチドおよびアンチセンスペプチド |
US6281335B1 (en) * | 1993-10-08 | 2001-08-28 | Coulter Corporation | Hybridoma and anti-KC-4 humanized monoclonal antibody |
US5792852A (en) * | 1992-11-16 | 1998-08-11 | Cancer Research Fund Of Contra Costa | Polynucleotides encoding modified antibodies with human milk fat globule specificity |
US5804187A (en) | 1992-11-16 | 1998-09-08 | Cancer Research Fund Of Contra Costa | Modified antibodies with human milk fat globule specificity |
JPH07203974A (ja) * | 1994-01-13 | 1995-08-08 | Tosoh Corp | 癌特異的ムチンを認識する抗体の遺伝子断片等 |
EP0781847A1 (en) * | 1995-11-06 | 1997-07-02 | MERCK PATENT GmbH | Humanized monoclonal antibody |
AU763029B2 (en) * | 1997-11-14 | 2003-07-10 | Euro-Celtique S.A. | Immunoglobulin molecules having a synthetic variable region and modified specificity |
GB2360771A (en) * | 2000-03-28 | 2001-10-03 | Antisoma Res Ltd | Compounds for targeting |
WO2001074905A1 (en) * | 2000-04-03 | 2001-10-11 | Antisoma Research Limited | Compounds for targeting |
AU2002307064A1 (en) * | 2001-04-02 | 2002-10-15 | Purdue Pharma L.P. | Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response |
GB0200657D0 (en) * | 2002-01-12 | 2002-02-27 | Antisoma Plc | Cancer treatment |
JP4753578B2 (ja) * | 2002-06-03 | 2011-08-24 | ジェネンテック, インコーポレイテッド | 合成抗体ファージライブラリー |
WO2004007687A2 (en) * | 2002-07-16 | 2004-01-22 | Stuart Bussell | Methods to construct multimeric dna and polymeric protein sequences as direct fusions or with linkers |
JP2007501011A (ja) * | 2003-08-01 | 2007-01-25 | ジェネンテック・インコーポレーテッド | 制限多様性配列を有する結合型ポリペプチド |
GB0519398D0 (en) * | 2005-09-23 | 2005-11-02 | Antisoma Plc | Biological materials and uses thereof |
WO2007056441A2 (en) | 2005-11-07 | 2007-05-18 | Genentech, Inc. | Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
EP1973951A2 (en) * | 2005-12-02 | 2008-10-01 | Genentech, Inc. | Binding polypeptides with restricted diversity sequences |
RU2600444C2 (ru) * | 2010-10-13 | 2016-10-20 | Янссен Байотек, Инк. | Человеческие антитела к онкостатину м и способы их применения |
US20140079722A1 (en) * | 2011-03-09 | 2014-03-20 | Centrose, Llc | Extracellular targeted drug conjugates |
RU2493165C1 (ru) * | 2012-02-28 | 2013-09-20 | Общество с ограниченной ответственностью "Технофарма" | Наноантитело, специфически связывающее белок muc1, способ детекции белка muc1 с помощью наноантител |
JP6416751B2 (ja) | 2012-04-30 | 2018-10-31 | バイオセラ インコーポレイテッド | β−グルカン免疫治療方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8607679D0 (en) * | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
AU1103988A (en) * | 1987-01-07 | 1988-07-27 | Imperial Cancer Research Technology Limited | Probe |
WO1988009344A1 (en) * | 1987-05-21 | 1988-12-01 | Creative Biomolecules, Inc. | Targeted multifunctional proteins |
AU3049189A (en) * | 1988-02-08 | 1989-08-25 | John Muir Cancer & Aging Institute | Monoclonal antibody specific to a novel mucin-like glycoprotein surface antigen on human carcinoma cells |
EP0442926A1 (en) * | 1988-11-10 | 1991-08-28 | Imperial Cancer Research Technology Limited | Polypeptides |
CA2003211A1 (en) | 1988-11-17 | 1990-05-17 | Pei-Xiang Xing | Monoclonal antibodies |
US5075219A (en) * | 1989-04-05 | 1991-12-24 | John Muir Cancer & Aging Institute | Monoclonal antibody which recognizes a specific glycoprotein of a human milk-fat globule membrane mucin antigen and said mucin antigen |
HUT64600A (en) * | 1989-11-17 | 1994-01-28 | Unilever Nv | Method for producing specific binding materials |
-
1990
- 1990-09-07 GB GB909019553A patent/GB9019553D0/en active Pending
-
1991
- 1991-09-05 DE DE69133200T patent/DE69133200T2/de not_active Expired - Lifetime
- 1991-09-05 DK DK91308147T patent/DK0483961T3/da active
- 1991-09-05 KR KR1019930700678A patent/KR930702526A/ko not_active Application Discontinuation
- 1991-09-05 HU HU9300609A patent/HUT67796A/hu unknown
- 1991-09-05 AU AU84953/91A patent/AU653167B2/en not_active Expired
- 1991-09-05 UA UA93080844A patent/UA46691C2/uk unknown
- 1991-09-05 CA CA002090961A patent/CA2090961C/en not_active Expired - Lifetime
- 1991-09-05 EP EP91308147A patent/EP0483961B1/en not_active Expired - Lifetime
- 1991-09-05 AT AT91308147T patent/ATE233279T1/de not_active IP Right Cessation
- 1991-09-05 WO PCT/GB1991/001511 patent/WO1992004380A1/en active IP Right Grant
- 1991-09-05 US US07/987,264 patent/US6204366B1/en not_active Expired - Lifetime
- 1991-09-05 ES ES91308147T patent/ES2193129T3/es not_active Expired - Lifetime
- 1991-09-05 RO RO93-00310A patent/RO113432B1/ro unknown
- 1991-09-05 JP JP51496191A patent/JP3514456B2/ja not_active Expired - Lifetime
- 1991-09-05 HU HU9300609A patent/HU9300609D0/hu unknown
-
1993
- 1993-03-05 NO NO19930825A patent/NO314595B1/no not_active IP Right Cessation
- 1993-03-05 FI FI930984A patent/FI113873B/fi not_active IP Right Cessation
- 1993-04-05 BG BG97607A patent/BG60716B1/bg unknown
-
2000
- 2000-12-28 US US09/749,831 patent/US20020086978A1/en not_active Abandoned
-
2001
- 2001-08-31 FI FI20011739A patent/FI114611B/fi not_active IP Right Cessation
- 2001-10-04 NO NO20014822A patent/NO315239B1/no not_active IP Right Cessation
-
2002
- 2002-05-30 JP JP2002157535A patent/JP2003061689A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ATE233279T1 (de) | 2003-03-15 |
CA2090961C (en) | 2004-01-20 |
AU653167B2 (en) | 1994-09-22 |
FI114611B (fi) | 2004-11-30 |
RO113432B1 (ro) | 1998-07-30 |
JP3514456B2 (ja) | 2004-03-31 |
FI113873B (fi) | 2004-06-30 |
JPH06500468A (ja) | 1994-01-20 |
WO1992004380A1 (en) | 1992-03-19 |
NO314595B1 (no) | 2003-04-14 |
DE69133200D1 (de) | 2003-04-03 |
HUT67796A (en) | 1995-04-28 |
NO20014822L (no) | 1993-05-05 |
FI930984A0 (fi) | 1993-03-05 |
NO930825D0 (no) | 1993-03-05 |
BG97607A (bg) | 1994-03-31 |
AU8495391A (en) | 1992-03-30 |
US6204366B1 (en) | 2001-03-20 |
UA46691C2 (uk) | 2002-06-17 |
DE69133200T2 (de) | 2003-11-20 |
EP0483961B1 (en) | 2003-02-26 |
NO315239B1 (no) | 2003-08-04 |
BG60716B1 (en) | 1996-01-31 |
HU9300609D0 (en) | 1993-05-28 |
CA2090961A1 (en) | 1992-03-08 |
NO20014822D0 (no) | 2001-10-04 |
DK0483961T3 (da) | 2003-06-23 |
ES2193129T3 (es) | 2003-11-01 |
KR930702526A (ko) | 1993-09-09 |
FI930984A (fi) | 1993-03-05 |
EP0483961A1 (en) | 1992-05-06 |
JP2003061689A (ja) | 2003-03-04 |
GB9019553D0 (en) | 1990-10-24 |
US20020086978A1 (en) | 2002-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO930825L (no) | Spesifikke bindingsreagenser | |
PT99934A (pt) | Processo para a producao de um anticorpo anti-htnf alfa recombinante ou humanizado | |
FI922220A (fi) | Specifika bindemedel. | |
DE69029808D1 (de) | Monoklonale antikörper | |
NO174110C (no) | Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet | |
DE3580524D1 (de) | Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen. | |
CA2259724A1 (en) | Monoclonal antibody which is specific for activated coagulation factor vii, and its use | |
DE3881101D1 (de) | Monoklonal-antikoerper und methode fuer die bereitung von hybridoma, produzierend diese antikoerper. | |
DE3787220T2 (de) | Monoklonaler Antikörper gegen menschliches Plasminogen, Verfahren zu seiner Herstellung, diesen Antikörper enthaltendes Testreagenz sowie Testsatz und diesen Antikörper produzierendes Hybridoma. | |
FR2697088B1 (fr) | Anticorps monoclonaux pour le diagnostic différentiel de cancers épithéliaux dans des épanchements séreux, hybridomes les secrétant et kit de diagnostic. | |
DK1414859T3 (da) | Monoklonale anti-SSRP-1-antistoffer og hybridomer som producerer antistofferne | |
RU93058456A (ru) | Антитела, способы диагностики, способ лечения, фармацевтическая композиция, клеточные линии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |